Skip to main
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 23%
Hold 23%
Sell 8%
Strong Sell 0%

Bulls say

Tempus AI is positioned for strong revenue growth through their unique combination of AI technology, real-world data, and value-added services. With FDA approval for their xT CDx platform and plans for expansion into other areas, their data business is expected to see significant growth. While risks such as volatile ordering patterns and government funding may present challenges, their focus on margin-accretive data revenue and expansion within the pharmaceutical industry puts them in a positive outlook for the future.

Bears say

Tempus AI is expected to experience 25%+ growth in the coming years, driven by FDA approval for tumor-only xT CDx and favorable pricing dynamics. Additionally, the company has a strong data and applications business, with a target of $650M in revenue by 2028. However, there are potential risks related to its commercial partner and volatility in budgets and ordering patterns from pharma companies. While the company has achieved positive cash flow and has a promising technology platform according to medical oncologists, there may be execution and focus risks in the future.

TEM has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 23% recommend Buy, 23% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 13 analysts, TEM has a Buy consensus rating as of Jun 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $69.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $69.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.